A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Wet Age-related Macular Degeneration

Interventions

DEVICE

NeoVista Ophthalmic System

A single procedure using the NeoVioasta Ophthalmic System plus an injection of Lucentis.

Trial Locations (2)

Medical Center Ophthalmology Associates, San Antonio

Ophthalmic Consultants of Boston, Boston